Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Urinary Retention Postoperative
In brief
The objectives of this study are to determine the feasibility of conducting a full-scale randomized control trial comparing the efficacy of tamsulosin compared to placebo in reducing post-operative urinary retention in people undergoing elective thoracic surgery.
Key facts
- Study ID
- NCT06262048
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- People needed
- 60
- Starts
- 2024-10-01
- Expected to finish
- 2026-02-01
- Last updated by the study team
- 2024-10-28
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Active treatment of Benign Prostatic Hyperplasia (BPH)
- Hypersensitivity or allergy to tamsulosin HCL
- Active treatment with tamsulosin or other alpha-blocker or uses of tamsulosin/ other alpha-blocker within 3 weeks of enrollment date
- Active urinary tract infection
- History of urological disorder specified as urethral stricture, BPH, bladder or prostate malignancy.
- History of urological surgery (Transurethral resection of the Prostate, Transurethral resection of the Bladder, Bladder suspension, prostatectomy)
- Underlying neurological disorders resulting in impaired bladder function
- Any known contraindication to the use of tamsulosin HCL
- Nursing/ Breastfeeding women
- Use of intraoperative bladder catheter
- patients for whom cataract and/or glaucoma surgery is scheduled.
- patients on strong inhibitors of CYP3A4 (e.g., ketoconazole), on moderate inhibitors of CYP3A4 (e.g., erythromycin), on strong (e.g. paroxetine), on moderate (e.g., terbinafine) inhibitors of CYP2D6 or in patients known to be CYP2D6 poor metabolizers.
- patients with a serious or life-threatening sulfa allergy
- patients with severe hepatic insufficiency
- patients with severe renal impairment (creatinine clearance of <10 mL/min)
- patients with a serious or life-threatening sulfa allergy
Where it is running
- London Health Sciences Centre — London, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.